107 related articles for article (PubMed ID: 19304511)
21. Involvement of calpain/p35-p25/Cdk5/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons.
Miao Y; Dong LD; Chen J; Hu XC; Yang XL; Wang Z
PLoS One; 2012; 7(8):e42318. PubMed ID: 22870316
[TBL] [Abstract][Full Text] [Related]
22. Involvement of cyclin-dependent kinase-5 in the kainic acid-mediated degeneration of glutamatergic synapses in the rat hippocampus.
Putkonen N; Kukkonen JP; Mudo G; Putula J; Belluardo N; Lindholm D; Korhonen L
Eur J Neurosci; 2011 Oct; 34(8):1212-21. PubMed ID: 21978141
[TBL] [Abstract][Full Text] [Related]
23. CDK5 activator protein p25 preferentially binds and activates GSK3β.
Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
[TBL] [Abstract][Full Text] [Related]
24. [Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway].
Xie YH; Chen XC; Zhang J; Huang TW; Song JQ; Fang YX; Pan XD; Lin ZY
Yao Xue Xue Bao; 2007 Aug; 42(8):828-32. PubMed ID: 17944229
[TBL] [Abstract][Full Text] [Related]
25. [Ginsenoside Rg1 protects rat hippocampal neurons from radiation injury by regulating NOS activity].
Chen Y; Sun AM; Chen ZX; Liu Y; Chen LH; Yuan YW
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1522-5. PubMed ID: 20650756
[TBL] [Abstract][Full Text] [Related]
26. Deregulation of cdk5 in Hippocampal sclerosis.
Sen A; Thom M; Martinian L; Jacobs T; Nikolic M; Sisodiya SM
J Neuropathol Exp Neurol; 2006 Jan; 65(1):55-66. PubMed ID: 16410749
[TBL] [Abstract][Full Text] [Related]
27. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.
Alvarez A; Muñoz JP; Maccioni RB
Exp Cell Res; 2001 Apr; 264(2):266-74. PubMed ID: 11262183
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits.
Liu W; Zhou Y; Liang R; Zhang Y
FASEB J; 2019 Dec; 33(12):14506-14515. PubMed ID: 31689375
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis.
Zheng YL; Hu YF; Zhang A; Wang W; Li B; Amin N; Grant P; Pant HC
J Neurol Sci; 2010 Dec; 299(1-2):101-7. PubMed ID: 20926102
[TBL] [Abstract][Full Text] [Related]
30. Aberrant activation of CDK5 is involved in the pathogenesis of OPIDN.
Wang YP; Mou DL; Song JF; Rao ZR; Li D; Ju G
J Neurochem; 2006 Oct; 99(1):186-97. PubMed ID: 16987246
[TBL] [Abstract][Full Text] [Related]
31. Cyclin-dependent kinase 5 activity regulates pain signaling.
Pareek TK; Keller J; Kesavapany S; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):791-6. PubMed ID: 16407116
[TBL] [Abstract][Full Text] [Related]
32. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
[TBL] [Abstract][Full Text] [Related]
33. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
34. S-nitrosylation-dependent proteasomal degradation restrains Cdk5 activity to regulate hippocampal synaptic strength.
Zhang P; Fu WY; Fu AK; Ip NY
Nat Commun; 2015 Oct; 6():8665. PubMed ID: 26503494
[TBL] [Abstract][Full Text] [Related]
35. Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA.
Takahashi M; Ishida M; Saito T; Ohshima T; Hisanaga S
Biochem Biophys Res Commun; 2014 May; 447(4):678-82. PubMed ID: 24755075
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of cyclin-dependent kinase 5 attenuates p53-dependent apoptosis of hippocampal CA1 pyramidal neurons following transient cerebral ischemia.
Shin BN; Kim DW; Kim IH; Park JH; Ahn JH; Kang IJ; Lee YL; Lee CH; Hwang IK; Kim YM; Ryoo S; Lee TK; Won MH; Lee JC
Sci Rep; 2019 Sep; 9(1):13032. PubMed ID: 31506563
[TBL] [Abstract][Full Text] [Related]
37. Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity.
Xu J; Tsutsumi K; Tokuraku K; Estes KA; Hisanaga S; Ikezu T
J Neurochem; 2011 Jan; 116(2):192-204. PubMed ID: 20492361
[TBL] [Abstract][Full Text] [Related]
38. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
[TBL] [Abstract][Full Text] [Related]
39. Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells.
Utreras E; Maccioni R; González-Billault C
Neuroscience; 2009 Jul; 161(4):978-87. PubMed ID: 19362124
[TBL] [Abstract][Full Text] [Related]
40. [Expression changes of cyclin dependent kinase 5/p35 in nerve tissues of 2, 5-hexanedione intoxicated rats].
Wang QS; Hou LY; Zhang CL; Zeng T; Yang XW; Xie KQ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jun; 26(6):336-40. PubMed ID: 18771616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
